Plummer-Vinson syndrome secondary prevention: Difference between revisions
(Created page with "__NOTOC__ {{Plummer-Vinson syndrome}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References=...") |
Akshun Kalia (talk | contribs) No edit summary |
||
| (6 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Plummer-Vinson syndrome}} | {{Plummer-Vinson syndrome}} | ||
{{CMG}}; {{AE}}{{Akshun}} | |||
==Overview== | |||
Patients of Plummer-Vinson syndrome are at a risk (10-15%) of developing [[malignant]] lesions ([[squamous cell carcinoma]]) of the [[oral mucosa]], [[hypopharynx]] and [[esophagus]]. Effective measures for the [[secondary prevention]] of Plummer-Vinson syndrome include an upper [[Gastrointestinal tract|gastrointestinal]] [[endoscopy]] every year to rule out [[malignant]] transformation. | |||
==Secondary Prevention== | |||
Patients of Plummer-Vinson syndrome are at a risk (10-15%) of developing [[malignant]] lesions ([[squamous cell carcinoma]]) of the [[oral mucosa]], [[hypopharynx]] and [[esophagus]]. Effective measures for the [[secondary prevention]] of Plummer-Vinson syndrome include:<ref name="pmid7575056">{{cite journal |vauthors=Hoffman RM, Jaffe PE |title=Plummer-Vinson syndrome. A case report and literature review |journal=Arch. Intern. Med. |volume=155 |issue=18 |pages=2008–11 |year=1995 |pmid=7575056 |doi= |url=}}</ref> | |||
*Upper gastrointestinal [[endoscopy]] every year to rule out [[malignant]] transformation. | |||
==References== | ==References== | ||
{{Reflist|2}} | |||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
Latest revision as of 19:01, 1 November 2017
|
Plummer-Vinson syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Plummer-Vinson syndrome secondary prevention On the Web |
|
American Roentgen Ray Society Images of Plummer-Vinson syndrome secondary prevention |
|
Risk calculators and risk factors for Plummer-Vinson syndrome secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Akshun Kalia M.B.B.S.[2]
Overview
Patients of Plummer-Vinson syndrome are at a risk (10-15%) of developing malignant lesions (squamous cell carcinoma) of the oral mucosa, hypopharynx and esophagus. Effective measures for the secondary prevention of Plummer-Vinson syndrome include an upper gastrointestinal endoscopy every year to rule out malignant transformation.
Secondary Prevention
Patients of Plummer-Vinson syndrome are at a risk (10-15%) of developing malignant lesions (squamous cell carcinoma) of the oral mucosa, hypopharynx and esophagus. Effective measures for the secondary prevention of Plummer-Vinson syndrome include:[1]